Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

In the current study, scientists generate and analyze genomic, transcriptomic, and T-cell receptor sequencing data of metastatic PDAC patients to explore molecular and immune differences between ...

Targeting this particular type of innate immune cells or interfering with ... macrophages restores tumor immunity and inhibits PDAC metastasis." Key contributor Professor Ainhoa Mielgo commented ...

New research uncovers how distinct molecular profiles and immune signatures in ... the prognosis of patients with metastatic pancreatic ductal adenocarcinoma (PDAC). PDAC is a highly aggressive ...

LOAd703, an oncolytic adenovirus with transgenes for 4-1BBL and TMZ-CD40L, has received FDA fast track designation for ...

We are interested in metastasis, the cause of 90% of cancer deaths. The lab investigates metastatic stem cells and their stromal niches. The role of immune regulatory and regenerative signals, ...

About GOBLET Cohort 5 The mFOLFIRINOX cohort of the Phase 1/2 GOBLET study is designed to evaluate newly diagnosed metastatic PDAC patients treated with pelareorep + mFOLFIRINOX with or without ...

In a new study, researchers at the University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal ...